Host defense genes in asthma and sepsis and the role of the environment

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 6, 2007, Pages 459-467

  Gao, Li ^a   Tsai, Yuhjung J ^a   Grigoryev, Dmitry N ^a   Barnes, Kathleen C ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Asthma; Lipopolysaccharide; Polymorphism; Sepsis

Indexed keywords

ACYOXYACYL HYDROLASE; CD14 ANTIGEN; MYOSIN LIGHT CHAIN KINASE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ASTHMA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD14; ASTHMA; ENVIRONMENT; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MYOSIN-LIGHT-CHAIN KINASE; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 35948987588     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3282f1fb9a     Document Type: Review

References (102)

1. Bjorkbacka H, Fitzgerald KA, Huet F, et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 2004; 19:319-330.
2. Jeyaseelan S, Chu HW, Young SK, Worthen GS. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 2004; 72:7247-7256.
3. Okamoto T, Gohil K, Finkelstein EI, et al. Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004; 286:L198-L209.
4. Schmitz F, Mages J, Heit A, et al. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Eur J Immunol 2004; 34:2863-2873.
5. Ma SF, Grigoryev DN, Taylor AD, et al. Bioinformatic identification of novel early stress response genes in rodent models of lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 289:L468-L477.
6. Srivastava M, Jung S, Wilhelm J, et al. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J Immunol 2005; 175:1884-1893.
7. Ye SQ, Simon BA, Maloney JP, et al. Pre-B-cell colony enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005; 171:361-370.
8. dos Santos CC, Han B, Andrade CF, et al. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 2004; 19:331-342.
9. Jiang H, Van De Ven C, Satwani P, et al. Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood. J Immunol 2004; 172:5870-5879.
10. Schiffer R, Baron J, Dagtekin G, et al. Differential regulation of the expression of transporters associated with antigen processing, TAP1 and TAP2, by cytokines and lipopolysaccharide in primary human macrophages. Inflamm Res 2002; 51:403-408.
11. Hansel NN, Diette GB. Gene expression profiling in human asthma. Proc Am Thorac Soc 2007; 4:32-36. This article reviewed expression profiling studies that have been performed in human asthmatic tissue samples and the potential advancements in this field were also discussed.
12. + T cells in asthma. Am J Respir Crit Care Med 2000; 161:1790-1796.
13. Walker C, Bode E, Boer L, et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146:109-115.
14. Brutsche MH, Brutsche IC, Wood P, et al. B-cell isotype control in atopy and asthma assessed with cDNA array technology. Am J Physiol Lung Cell Mol Physiol 2001; 280:L627-L637.
15. Brutsche MH, Joos L, Carlen Brutsche IE, et al. Array-based diagnostic gene-expression score for atopy and asthma. J Allergy Clin Immunol 2002; 109:271-273.
16. Burczynski ME, Dorner AJ. Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics 2006; 7:187-202.
17. Satyanarayana M. New technique uses blood cells as a 'Sentinel' for diseases elsewhere in the body. Affymetrix Microarray Bull 2006; 2:1-5. This is an overview and justification of genomics approaches for gene expression profiling of peripheral blood from patients with different pathologies.
18. Fukuda T, Mochida S, Fukushima Y, Makino S. Detection of allergen-induced genes in peripheral blood mononuclear cells of patients with allergic asthma using subtractive hybridization. J Allergy Clin Immunol 1995; 96 (6 Pt 2):1076-1082.
19. + T cells. J Allergy Clin Immunol 2007; 119:488-497.
20. Baldini M, Lohman IC, Halonen M, et al. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
21. Gao PS, Mao XQ, Baldini M, et al. Serum total IgE levels and CD14 on chromosome 5q31. Clin Genet 1999; 56:164-165.
22. Leung TF, Tang NL, Sung YM, et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003; 14:255-260.
23. Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Cell Mol Biol 2001; 163:965-969.
24. Buckova D, Holla LI, Schuller M, et al. Two CD14 promoter polymorphisms and atopic phenotypes in Czech patients with IgE-mediated allergy. Allergy 2003; 58:1023-1026.
25. Choudhry S, Avila PC, Nazario S, et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am J Respir Crit Care Med 2005; 172:173-182.
26. Sackesen C, Karaaslan C, Keskin O, et al. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy 2005; 60:1485-1492.
27. Woo JG, Assa'ad A, Heizer AB, et al. The -159 C→T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol 2003; 112:438-444.
28. Sharma M, Batra J, Mabalirajan U, et al. Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations. Immunogenetics 2004; 56:544-547.
29. Martin AC, Laing IA, Khoo SK, Zhang G, Rueter K, Teoh L, et al. Acute asthma in children: relationship between cd14 and cc16 genotype, plasma levels and severity. Am J Respir Crit Care Med 2006; 173:617-622.
30. Zambelli-Weiner A, Ehrlich E, Stockton ML, et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol 2005; 115: 1203-1209.
31. + monocytes but not alveolar macrophages after lipopolysaccharide (LPS) stimulation by genomic expression profiling [abstract]. J Allergy Clin Immunol 2007; 119:S175-S176.
32. Becker KG, Hosack DA, Dennis G Jr, et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 2003; 4:61.
33. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34:15-21.
34. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
35. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554.
36. Villar J, Maca-Meyer N, Perez-Mendez L, Flores C. Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit Care 2004; 8:180-189.
37. Moss M. Clinical year in review II: interstitial lung disease, sepsis, pulmonary infections, and sleep medicine. Proc Am Thorac Soc 2007; 4:482-488.
38. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-732.
39. Sutherland AM, Russell JA. Issues with polymorphism analysis in sepsis. Clin Infect Dis 2005; 41 (Suppl 7):S396-S402.
40. Gao L, Grant AV, Rafaels N, et al. Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma. J Allergy Clin Immunol 2007; 119:1111-1118. This study provided important evidence that MYLK polymorphisms may function as a common genetic factor in clinically distinct diseases involving bronchial smooth muscle contraction and vascular endothelium-regulated lower airway inflammation. Findings in this study also support the 'common variant/multiple disease' hypothesis.
41. Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003; 81:85-91.
42. Lazarus R, Raby BA, Lange C, et al. Toll-like receptor 10 (TLR10) genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004; 170:594-600.
43. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
44. Qureshi ST, Lariviere L, Leveque G, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189:615-625.
45. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749-3752.
46. Hollingsworth JW 2nd, Cook DN, Brass DM, et al. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 2004; 170:126-132.
47. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-191.
48. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192.
49. Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186:1522-1525.
50. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028-1032.
51. Barber RC, Aragaki CC, Rivera-Chavez FA, et al. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004; 41:808-813.
52. Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, et al. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004; 114:561-567.
53. Werner M, Topp R, Wimmer K, et al. TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003; 112:323-330.
54. Yang IA, Barton SJ, Rorke S, et al. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004; 5:41-45.
55. van der Graaf C, Kullberg BJ, Joosten L, et al. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 2005; 30:264-268.
56. Eder W, Klimecki W, Yu L, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-488.
57. Hoffjan S, Stemmler S, Parwez Q, et al. Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med Genet 2005; 6:34.
58. Yang IA, Fong KM, Holgate ST, Holloway JW. The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 2006; 6:23-28.
59. Landmann R, Reber AM, Sansano S, Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 1996; 173:661-668.
60. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-414.
61. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167:5838-5844.
62. Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:937-944.
63. Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005; 33:638-644.
64. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006; 7:95-100. This article provides an overview of the current status of asthma genetic research by reviewing 500 papers on asthma association studies.
65. Alexis N, Eldridge M, Reed W, et al. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol 2001; 107:31-35.
66. Rey Nores JE, Bensussan A, Vita N, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999; 29:265-276.
67. Arias MA, Rey Nores JE, Vita N, et al. Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 2000; 164:3480-3485.
68. Hall CL, Munford RS. Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils. Proc Natl Acad Sci U S A 1983; 80:6671-6675.
69. Munford RS, Hall CL. Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. J Biol Chem 1989; 264:15613-15619.
70. Hagen FS, Grant FJ, Kuijper JL, et al. Expression and characterization of recombinant human acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides. Biochemistry 1991; 30:8415-8423.
71. Munford RS, Hall CL. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986; 234:203-205.
72. Pohlman TH, Munford RS, Harlan JM. Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med 1987; 165:1393-1402.
73. Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 1992; 1760:485-494.
74. Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 1985; 48:464-473.
75. Lu M, Zhang M, Kitchens RL, et al. Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med 2003; 197:1745-1754.
76. Feulner JA, Lu M, Shelton JM, et al. Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infect Immun 2004; 72:3171-3178.
77. Whitmore TE, Mathewes SL, O'Hara PJ, Durnam DM. Chromosomal localization of the acyloxyacyl hydrolase (AOAH) gene to 7p14-p12 using fluorescence in situ hybridization. Genomics 1994; 21:457-458.
78. Daniels SE, Bhattacharrya S, James A, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996; 383:247-250.
79. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000; 162:1812-1818.
80. Laitinen T, Daly MJ, Rioux JD, et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 2001; 28:87-91.
81. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13:464-468.
82. Allen EM, Hsueh WC, Sabra MM, et al. A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3. J Clin Endocrinol Metab 2003; 88:1292-1296.
83. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14:199-202.
84. Gaffney PM, Ortmann WA, Selby SA, et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000; 66:547-556.
85. Barnes KC, Grant A, Gao P, et al. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J Allergy Clin Immunol 2006; 118:70-77. This study reported the novel association between AOAH gene polymorphisms and risk of asthma and associated quantitative traits (IgE and cytokine levels) among asthmatic patients and their families in Barbados, and the interactive effect on total IgE and asthma concentrations between an AOAH polymorphism and the functional CD14(-260)C > T polymorphism.
86. Gao L, Grant A, Zhang S, et al. Single nucleotide polymorphisms in the gene encoding acyloxyacyl hydrolase (AOAH) and a potential role in sepsis-associated acute lung injury. Am J Respir Crit Care Med 2005; 171:A151.
87. Gao L, Grant A, Halder I, et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006; 34:487-495. This study was the first to report that the MYLK gene is associated with severe sepsis and sepsis-associated lung injury, supporting previous findings that the chromosome 3q21.1 region, where the MYLK gene is located, is important for various inflammatory disorders, including asthma, allergic rhinitis, chronic obstructive pulmonary disease and atopic dermatitis.
88. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 1995; 163:510-522.
89. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91:1487-1500.
90. Garcia JG, Verin AD, Herenyiova M, English D. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J Appl Physiol 1998; 84:1817-1821.
91. Petrache I, Verin AD, Crow MT, et al. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1168-L1178.
92. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372:231-236.
93. Sweeney HL. Regulation and tuning of smooth muscle myosin. American J Respir Crit Care Med 1998; 158:S95-S99.
94. Mackay TF. The genetic architecture of quantitative traits. Annu Rev Genet 2001; 35:303-339.
95. Erickson D. Quantitative trait loci: mapping the future of QTL's. Heredity 2005; 95:417-418.
96. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J 2007; 29:179-184. This article discusses the 'context-dependent genetic determinants of diseases' elucidating the complex interactions between asthma-related polymorphisms determining risk for the disease and environmental factors and polymorphisms in other genes.
97. Howard TD, Koppelman GH, Xu J, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002; 70:230-236.
98. Grischkan J, Storfer-Isser A, Rosen CL, et al. Variation in childhood asthma among former preterm infants. J Pediatr 2004; 144:321-326.
99. MacDermott RP. Treatment of irritable bowel syndrome in outpatients with inflammatory bowel disease using a food and beverage intolerance, food and beverage avoidance diet. Inflamm Bowel Dis 2007; 13:91-96.
100. Palmieri O, Latiano A, Bossa F, et al. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Aliment Pharmacol Ther 2007; 26:737-745.
101. Kim YK, Oh SY, Jeon SG, et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007; 178:5375-5382. The authors indicate that high levels of LPS induce a type 1 asthma phenotype, while low levels of LPS induce type 2 asthma in a mouse model.
102. Joshi VD, Kalvakolanu DV, Hebel JR, et al. Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia. Infect Immun 2002; 70:6896-6903.